Alnylam Pharmaceuticals | ALNY - 营业利润

股票价格

321.18

每天变化

-6.07 -1.85%

每月一次

-0.37%

每年

41.94%

Q2 预测

309.25

金融业

USD

USD 4.97B

现金及等价物

USD 1.66B

USD 267.72M

USD 4.05B

USD 1.47B

USD 1.31B

USD 29.4M

USD 145.22M

2.23K

EPS每股收益

USD 1.25

股本和储备

USD 789.18M

USD 829.31M

债务利息支出

USD 129.34M

USD 28.68M

USD 2.48B

USD 41.47B

USD 186.42M

USD 965.32M

USD 29.4M

普通股股本

USD 132.38M

170.7

USD 161.14M

USD 1.1B

销售和管理费用

USD 285.06M

USD 82.72M

贸易债权人

USD 115.72M

应收帐款人

USD 777.57M

	营业利润	更改		日
Acadia Pharmaceuticals	USD 17.39M		18.36M	2025-12
Agios Pharmaceuticals	USD -121.58M		4.71M	2025-12
Alnylam Pharmaceuticals	USD 29.4M		59.36M	2025-12
Amgen	USD 3.96B		464M	2025-12
Arrowhead Research	USD 40.81M		3.3M	2025-12
BioCryst Pharmaceuticals	USD 260.38M		230.79M	2025-12
BioMarin Pharmaceutical	USD 198.39M		230.08M	2025-12
Incyte	USD 383.88M		47.43M	2025-12
Ionis Pharmaceuticals	USD -215M		54.82M	2025-12
Moderna	USD -857M		597M	2025-12
Neurocrine Biosciences	USD 227.9M		11.4M	2025-12
Novartis	USD 4.06B		521M	2025-12
PTC Therapeutics	USD -81.62M		85.11M	2025-12
Regeneron Pharmaceuticals	USD 898.6M		211.3M	2025-12
Sangamo BioSciences	USD -33.51M		12.77M	2024-06
Sanofi	EUR 1.5B		2.29B	2025-12
Sarepta Therapeutics	USD -410.08M		347.2M	2025-12
Takeda	JPY 168.82B		479.89B	2025-12
Tectonic Therapeutic	USD -21.52M		374K	2025-12
Ultragenyx Pharmaceutical	USD -114M		56.89M	2025-12
Vertex Pharmaceuticals	USD 1.26B		24.5M	2025-12
Xencor	USD -53.63M		6.11M	2025-12